Evraz (EVRZF) & The Competition Head to Head Contrast

Evraz (OTCMKTS: EVRZF) is one of 22 publicly-traded companies in the “Blast furnaces & steel mills” industry, but how does it contrast to its peers? We will compare Evraz to similar businesses based on the strength of its valuation, dividends, risk, earnings, analyst recommendations, institutional ownership and profitability.

Earnings & Valuation

This table compares Evraz and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Evraz $10.83 billion N/A 12.23
Evraz Competitors $12.38 billion $665.62 million 16.16

Evraz’s peers have higher revenue and earnings than Evraz. Evraz is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

65.2% of shares of all “Blast furnaces & steel mills” companies are held by institutional investors. 3.9% of shares of all “Blast furnaces & steel mills” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Evraz and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Evraz N/A N/A N/A
Evraz Competitors 4.34% 10.81% 3.48%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Evraz and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evraz 0 0 0 0 N/A
Evraz Competitors 308 910 1080 55 2.37

As a group, “Blast furnaces & steel mills” companies have a potential upside of 8.95%. Given Evraz’s peers higher possible upside, analysts clearly believe Evraz has less favorable growth aspects than its peers.

Risk and Volatility

Evraz has a beta of -3.39, suggesting that its share price is 439% less volatile than the S&P 500. Comparatively, Evraz’s peers have a beta of 1.39, suggesting that their average share price is 39% more volatile than the S&P 500.

Summary

Evraz peers beat Evraz on 9 of the 9 factors compared.

Receive News & Ratings for Evraz Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evraz and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Investment Analysts’ Weekly Ratings Updates for Rhoen Klinikum
Investment Analysts’ Weekly Ratings Updates for Rhoen Klinikum
Verint Systems Sees Unusually Large Options Volume
Verint Systems Sees Unusually Large Options Volume
Kura Oncology Sees Unusually Large Options Volume
Kura Oncology Sees Unusually Large Options Volume
TopBuild  Hits New 52-Week High and Low at $84.52
TopBuild Hits New 52-Week High and Low at $84.52
Nu Skin Enterprises  Sets New 52-Week High and Low at $81.72
Nu Skin Enterprises Sets New 52-Week High and Low at $81.72
Jaguar Health  Shares Gap Down to $0.14
Jaguar Health Shares Gap Down to $0.14


© 2006-2018 Ticker Report. Google+.